Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Proactively manage your pharmacy inventory
Manage your formulary budget
Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
Find generic entry opportunities
|Title:||Hyperlipemia therapeutic agent|
|Abstract:||The present invention relates to a hyperlipemia therapeutic agent comprising pitavastatins and eicosapentaenoic acid or an ester derivative thereof as effective ingredients.According to the present invention, a type IIb and type IV hyperlipemia therapeutic agent having an excellent effect of lowering the cholesterol and triglyceride in blood is provided.|
|Inventor(s):||Aoki; Taro (Tokorozawa, JP), Yamaguchi; Junji (Higashimurayama, JP), Sasaki; Yusuke (Higashimurayama, JP)|
|Assignee:||KOWA Co., Ltd. (Nagoya, JP) Nissan Chemical Industries, Ltd. (Tokyo, JP)|
1. A method for treating hypertriglyceridemia in a patient in need of such treatment comprising administering a synergistically effective blood-triglyceride decreasing amount
of a combination of a pitavastatin and eicosapentaenoic acid or an ester thereof.
2. A method according to claim 1, wherein the pitavasitin is pitavastin calcium and the eicosapentaenoic acid or ester thereof is ethyl eicosapentaenoate.